Stay updated on Atezo & Tiragolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.

Latest updates to the Atezo & Tiragolumab in NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry 'Revision: v3.7.0' was added to the version history, indicating an update to the record. The previous 'Revision: v3.6.6' entry was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history now includes a new revision entry v3.6.6, indicating an update to the record. The prior revision v3.6.5 has been removed from the visible history.SummaryDifference0.1%

- Check76 days agoChange DetectedNew revision entry v3.6.5 has been added to the record history. The previous entry v3.6.4 has been removed, updating the version-history log to reflect the latest change.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, while the previous revision v3.6.3 was removed from the list.SummaryDifference0.1%

Stay in the know with updates to Atezo & Tiragolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo & Tiragolumab in NSCLC Clinical Trial page.